Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
André C. Ferreira(Fernando Pessoa University), Thiago Moreno L. Souza(National Institute of Science and Technology), Carolina Q. Sacramento(National Institute of Science and Technology), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Amílcar Tanuri(Universidade Federal do Rio de Janeiro), Priscila de Paiva Silva(Fundação Oswaldo Cruz), Karin Brüning(Bruning (Brazil)), Giselle Barbosa-Lima(Fundação Oswaldo Cruz), Fernando A. Bozza(D’Or Institute for Research and Education), Loraine Campanati(Universidade Federal do Rio de Janeiro), Hugo Caire de Castro Faria Neto(Fundação Oswaldo Cruz), Mayara Mattos(Fundação Oswaldo Cruz), Camila Zaverucha-do-Valle(Fundação Oswaldo Cruz), Patrícia A. Reis(Fundação Oswaldo Cruz), Yasmine Rangel Vieira(Fundação Oswaldo Cruz)
Cited by 115
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Evolution and epidemic spread of SARS-CoV-2 in Brazil
|Science|2020|658
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530